• The Korean Journal of Applied Statistics
• /
• v.28 no.4
• /
• pp.781-805
• /
• 2015

The National Welfare Pension Act of 1973 and the National Pension Act of 1986 were legislated for an anticipative response to future population ageing. But the enforcement of these acts gained momentum as they became effective tools to realize the present potential demographic bonus. This article investigates the history related to the enactment of these two acts, focusing on these acts' role in raising funds managed by the government (National Investment Fund and National Housing Fund). This article shows the historical origin of full-dress debates on the sustainability of the National Pension Fund.

• International Area Studies Review
• /
• v.20 no.2
• /
• pp.113-140
• /
• 2016

This paper first extracts the main basis for the Middle-Income Trap(MIT) to apply these grounds to reality of the Chinese economy. And then confirmed crisis factors of China economy. Also discussed then the economic reforms of China in order to not fall into the MIT. After reviewing previous research extracted six factors the results will correspond to comply with the Chinese economy. Those are 'Over-investment', 'excess capacity' 'reduction of TFP continued,' 'disappearance and the aging of the population bonus', 'excessive debt and structural adjustment and financial instability of the company', 'income unequal expansion', 'low financial and information infrastructure accessibility', and 'low transparency index'. China's policy direction to avoid the MIT generally set properly, but proof that implementation process not easy, was appearing everywhere. After all, China economy should be modified now to a reforms of 'government failure' and promotion of function for ongoing restructuring system in the market. Because of the SDR incorporation from 2015, it is inevitable to face major constraints in the external aspects.

• The Science & Technology
• /
• v.28 no.8 s.315
• /
• pp.75-79
• /
• 1995

최근 미국의 생명공학 기업인 암젠사가 이른바 "비만유전자(OB gene)"의 독점 사용권계약을 맺기위한 보너스로 이 유전자 발견자와 기관에게 2천만달러 (약1백60억원)라는 거액을 선뜻 지불하여 큰 화제가 되고 있다. 미국 록펠러대학 하워드 휴즈의학연구소의 분자유전학자 제프리 프리드만(Jefferey Friedman)과 그의 동료과학자들이 1994년 말 발견,복제에 성공한 쥐의 "비만증 유전자"는 돌연변이를 할때 쥐에게 심각한 유전적 비만증을 일으킨다는 사실이 드러났다. 이들은 다시 인간에게서도 이와 비슷한 유전자를 발견했는데 만약에 쥐의 경우와 같은 작용을 한다면 미국 인구의 3분의 1을 포함하여 전세계의 1억이 훨씬 넘는 비만증 환자들을 쉽게 치료할 수 있는 길이 열릴 수 있다고 암젠사는 기대하고 있다.